Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma.

Yamamoto S, Kato M, Takeyama Y, Azuma Y, Yukimatsu N, Hirayama Y, Otoshi T, Yamasaki T, Fujioka M, Gi M, Wanibuchi H, Uchida J

Open source

DOI
10.1038/s41416-023-02244-8
Published
2023 Jun
Container
British journal of cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41416-023-02244-8,
  title = {Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma.},
  author = {Yamamoto S and Kato M and Takeyama Y and Azuma Y and Yukimatsu N and Hirayama Y and Otoshi T and Yamasaki T and Fujioka M and Gi M and Wanibuchi H and Uchida J},
  year = {2023},
  journal = {British journal of cancer},
  doi = {10.1038/s41416-023-02244-8},
  url = {https://doi.org/10.1038/s41416-023-02244-8}
}

RIS

TY  - JOUR
TI  - Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma.
AU  - Yamamoto S
AU  - Kato M
AU  - Takeyama Y
AU  - Azuma Y
AU  - Yukimatsu N
AU  - Hirayama Y
AU  - Otoshi T
AU  - Yamasaki T
AU  - Fujioka M
AU  - Gi M
AU  - Wanibuchi H
AU  - Uchida J
PY  - 2023
JO  - British journal of cancer
DO  - 10.1038/s41416-023-02244-8
UR  - https://doi.org/10.1038/s41416-023-02244-8
ER  - 

APA

S, Y., M, K., Y, T., Y, A., N, Y., Y, H., T, O., T, Y., M, F., M, G., H, W., & J, U. (2023). Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma.. British journal of cancer. https://doi.org/10.1038/s41416-023-02244-8

Source records